Diabetes Technology

Latest News

Smartphone Apps for T2D Self-Management Lack Decision Support, Patient Education

By

Tyler Rice

Few smartphone apps for self-management of type 2 diabetes provide sufficient real-time action prompts or education on blood glucose monitoring.

G6 CGM System Offers Improved Accuracy in Youth and Adults With Diabetes

By

Endocrinology Advisor Contributing Writer

Investigators evaluate the performance of the G6 factory-calibrated continuous glucose monitoring system over 10 days.

FDA Approves FreeStyle Libre 14 Day Flash Glucose Monitoring System

By

Da Hee Han, PharmD

The new Flash Glucose Monitoring System enables patients to wear the sensor for up to 14 days compared with the existing FreeStyle Libre System that was approved for 10-day wear.

Improved Glycemic Control With Closed-Loop Insulin Delivery System

By

M. Tewar, MD

Researchers conducted a randomized, open-label trial to assess the effect of an automated closed-loop insulin delivery system on glycemic control in hospitalized patients.

Technosphere Inhaled Insulin Improves Glycemic Control in Type 1 Diabetes

By

Hannah Dellabella

Patients were randomly assigned to receive insulin aspart or Technosphere inhaled insulin.

Safety and Performance of Omnipod HCL for Children With Type 1 Diabetes

By

Jennifer Mannheim

In children with type 1 diabetes, the Omnipod hybrid closed-loop personal model system was safe and performed well.

ITCA 650 Shows Efficacy in Reducing Weight, HbA1c in Type 2 Diabetes

By

Endocrinology Advisor Contributing Writer

The ITCA 650, a small titanium osmotic mini-pump, provides a subcutaneous infusion of exenatide over 3 or 6 months.

Continuous Glucose Monitoring Controls Hypoglycemia Better Than Glucometer

By

Endocrinology Advisor Contributing Writer

Participants completed surveys for fear of hypoglycemia, hypoglycemia unawareness, and problem areas in diabetes questionnaire.

Implantable Continuous Glucose Monitoring Device Safe, Effective for Adolescents

By

Hannah Dellabella

The safety assessment included incidence of insertion or procedure-related removal and device-related serious adverse events through 180 after insertion.

First CGM System With Implantable Glucose Sensor Approved

By

Steve Duffy

The sensor is coated with a fluorescent chemical which produces a small amount of light when exposed to blood glucose.

FDA Clears Omnipod DASH System for Diabetes Management

By

Da Hee Han, PharmD

The Omnipod DASH system consists of a discreet, tubeless, waterproof Pod which is worn on the body, and the Personal Diabetes Manager (PDM), a handheld wireless device used to control the Pod.